Human epidermal growth factor receptor 2 (HER2) expression has been shown to correlate with response to NAC, with HER2-positive tumours demonstrating significantly higher rates of achieving pathological complete response than those of HER2-normal tumours [13]. This evidence concerns the gene ERBB2 and neoplasm.